APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Personalized Therapy Biosimulation Platform

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Personalized Therapy Biosimulation Platform Market Analysis and Forecast 2026-2032

Report ID 174502860512 August 2026177 pages

Choose your research edition.

Industry ResearchPersonalized Therapy Biosimulation Platform Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Personalized Therapy Biosimulation Platform Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Personalized Therapy Biosimulation Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Personalized Therapy Biosimulation Platform Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Personalized Therapy Biosimulation Platform Market Analysis and Forecast 2026-2032177 pages · $4,950 USD

Market perspective

The global Personalized Therapy Biosimulation Platform market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Personalized Therapy Biosimulation Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Personalized Therapy Biosimulation Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Personalized Therapy Biosimulation Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Personalized Therapy Biosimulation Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Personalized Therapy Biosimulation Platform include Schrodinger, In Silico Biosciences, Genedata, Physiomics, Insilico Biotechology, Chemical Computing Group ULC(CCG), Evidera, AnyLogic and Shanghai Lide, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Personalized Therapy Biosimulation Platform, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Personalized Therapy Biosimulation Platform, also provides the revenue of main regions and countries. Of the upcoming market potential for Personalized Therapy Biosimulation Platform, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Personalized Therapy Biosimulation Platform revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Personalized Therapy Biosimulation Platform market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Personalized Therapy Biosimulation Platform revenue, projected growth trends, production technology, application and end-user industry.

Personalized Therapy Biosimulation Platform Segment by Company

Schrodinger

In Silico Biosciences

Genedata

Physiomics

Insilico Biotechology

Chemical Computing Group ULC(CCG)

Evidera

AnyLogic

Shanghai Lide

Cellworks Group

Certara

Simulation Plus

Personalized Therapy Biosimulation Platform Segment by Type

Pharmacokinetic

Pharmacoeconomics

Personalized Therapy Biosimulation Platform Segment by Application

Pharmaceutical and Biotech Companies

Research Institutions

Hospital

Others

Personalized Therapy Biosimulation Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Personalized Therapy Biosimulation Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Personalized Therapy Biosimulation Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Personalized Therapy Biosimulation Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Personalized Therapy Biosimulation Platform in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Personalized Therapy Biosimulation Platform company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Personalized Therapy Biosimulation Platform revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Personalized Therapy Biosimulation Platform Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Pharmacokinetic Major Player Table 3. Pharmacoeconomics Major Player Table 4. Global Personalized Therapy Biosimulation Platform Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Pharmaceutical and Biotech Companies Major Player Table 6. Research Institutions Major Player Table 7. Hospital Major Player Table 8. Others Major Player Table 9. Personalized Therapy Biosimulation Platform Industry Trends Table 10. Personalized Therapy Biosimulation Platform Industry Drivers Table 11. Personalized Therapy Biosimulation Platform Industry Opportunities and Challenges Table 12. Personalized Therapy Biosimulation Platform Industry Restraints Table 13. Global Personalized Therapy Biosimulation Platform Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Personalized Therapy Biosimulation Platform Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Personalized Therapy Biosimulation Platform Market Share by Region (2021-2026) Table 16. Global Personalized Therapy Biosimulation Platform Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Personalized Therapy Biosimulation Platform Market Share by Region (2027-2032) Table 18. Global Personalized Therapy Biosimulation Platform Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Personalized Therapy Biosimulation Platform Revenue Market Share by Players (2021-2026) Table 20. Global Personalized Therapy Biosimulation Platform Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Personalized Therapy Biosimulation Platform Key Players Headquarters & Area Served Table 22. Global Personalized Therapy Biosimulation Platform Players, Product Type & Application Table 23. Global Personalized Therapy Biosimulation Platform Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Personalized Therapy Biosimulation Platform by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Personalized Therapy Biosimulation Platform Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Personalized Therapy Biosimulation Platform Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Personalized Therapy Biosimulation Platform Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Personalized Therapy Biosimulation Platform Revenue Market Share by Type (2021-2026) Table 30. Global Personalized Therapy Biosimulation Platform Revenue Market Share by Type (2027-2032) Table 31. Global Personalized Therapy Biosimulation Platform Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Personalized Therapy Biosimulation Platform Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Personalized Therapy Biosimulation Platform Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Personalized Therapy Biosimulation Platform Revenue Market Share by Application (2021-2026) Table 35. Global Personalized Therapy Biosimulation Platform Revenue Market Share by Application (2027-2032) Table 36. Schrodinger Company Information Table 37. Schrodinger Business Overview Table 38. Schrodinger Personalized Therapy Biosimulation Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Schrodinger Personalized Therapy Biosimulation Platform Product Portfolio Table 40. Schrodinger Recent Development Table 41. In Silico Biosciences Company Information Table 42. In Silico Biosciences Business Overview Table 43. In Silico Biosciences Personalized Therapy Biosimulation Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. In Silico Biosciences Personalized Therapy Biosimulation Platform Product Portfolio Table 45. In Silico Biosciences Recent Development Table 46. Genedata Company Information Table 47. Genedata Business Overview Table 48. Genedata Personalized Therapy Biosimulation Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Genedata Personalized Therapy Biosimulation Platform Product Portfolio Table 50. Genedata Recent Development Table 51. Physiomics Company Information Table 52. Physiomics Business Overview Table 53. Physiomics Personalized Therapy Biosimulation Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Physiomics Personalized Therapy Biosimulation Platform Product Portfolio Table 55. Physiomics Recent Development Table 56. Insilico Biotechology Company Information Table 57. Insilico Biotechology Business Overview Table 58. Insilico Biotechology Personalized Therapy Biosimulation Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Insilico Biotechology Personalized Therapy Biosimulation Platform Product Portfolio Table 60. Insilico Biotechology Recent Development Table 61. Chemical Computing Group ULC(CCG) Company Information Table 62. Chemical Computing Group ULC(CCG) Business Overview Table 63. Chemical Computing Group ULC(CCG) Personalized Therapy Biosimulation Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Chemical Computing Group ULC(CCG) Personalized Therapy Biosimulation Platform Product Portfolio Table 65. Chemical Computing Group ULC(CCG) Recent Development Table 66. Evidera Company Information Table 67. Evidera Business Overview Table 68. Evidera Personalized Therapy Biosimulation Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Evidera Personalized Therapy Biosimulation Platform Product Portfolio Table 70. Evidera Recent Development Table 71. AnyLogic Company Information Table 72. AnyLogic Business Overview Table 73. AnyLogic Personalized Therapy Biosimulation Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. AnyLogic Personalized Therapy Biosimulation Platform Product Portfolio Table 75. AnyLogic Recent Development Table 76. Shanghai Lide Company Information Table 77. Shanghai Lide Business Overview Table 78. Shanghai Lide Personalized Therapy Biosimulation Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Shanghai Lide Personalized Therapy Biosimulation Platform Product Portfolio Table 80. Shanghai Lide Recent Development Table 81. Cellworks Group Company Information Table 82. Cellworks Group Business Overview Table 83. Cellworks Group Personalized Therapy Biosimulation Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Cellworks Group Personalized Therapy Biosimulation Platform Product Portfolio Table 85. Cellworks Group Recent Development Table 86. Certara Company Information Table 87. Certara Business Overview Table 88. Certara Personalized Therapy Biosimulation Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Certara Personalized Therapy Biosimulation Platform Product Portfolio Table 90. Certara Recent Development Table 91. Simulation Plus Company Information Table 92. Simulation Plus Business Overview Table 93. Simulation Plus Personalized Therapy Biosimulation Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Simulation Plus Personalized Therapy Biosimulation Platform Product Portfolio Table 95. Simulation Plus Recent Development Table 96. North America Personalized Therapy Biosimulation Platform Revenue by Type (2021-2026) & (US$ Million) Table 97. North America Personalized Therapy Biosimulation Platform Revenue by Type (2027-2032) & (US$ Million) Table 98. North America Personalized Therapy Biosimulation Platform Revenue by Application (2021-2026) & (US$ Million) Table 99. North America Personalized Therapy Biosimulation Platform Revenue by Application (2027-2032) & (US$ Million) Table 100. North America Personalized Therapy Biosimulation Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. North America Personalized Therapy Biosimulation Platform Revenue by Country (2021-2026) & (US$ Million) Table 102. North America Personalized Therapy Biosimulation Platform Revenue by Country (US$ Million) & (2027-2032) Table 103. Europe Personalized Therapy Biosimulation Platform Revenue by Type (2021-2026) & (US$ Million) Table 104. Europe Personalized Therapy Biosimulation Platform Revenue by Type (2027-2032) & (US$ Million) Table 105. Europe Personalized Therapy Biosimulation Platform Revenue by Application (2021-2026) & (US$ Million) Table 106. Europe Personalized Therapy Biosimulation Platform Revenue by Application (2027-2032) & (US$ Million) Table 107. Europe Personalized Therapy Biosimulation Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Europe Personalized Therapy Biosimulation Platform Revenue by Country (2021-2026) & (US$ Million) Table 109. Europe Personalized Therapy Biosimulation Platform Revenue by Country (US$ Million) & (2027-2032) Table 110. China Personalized Therapy Biosimulation Platform Revenue by Type (2021-2026) & (US$ Million) Table 111. China Personalized Therapy Biosimulation Platform Revenue by Type (2027-2032) & (US$ Million) Table 112. China Personalized Therapy Biosimulation Platform Revenue by Application (2021-2026) & (US$ Million) Table 113. China Personalized Therapy Biosimulation Platform Revenue by Application (2027-2032) & (US$ Million) Table 114. Asia Personalized Therapy Biosimulation Platform Revenue by Type (2021-2026) & (US$ Million) Table 115. Asia Personalized Therapy Biosimulation Platform Revenue by Type (2027-2032) & (US$ Million) Table 116. Asia Personalized Therapy Biosimulation Platform Revenue by Application (2021-2026) & (US$ Million) Table 117. Asia Personalized Therapy Biosimulation Platform Revenue by Application (2027-2032) & (US$ Million) Table 118. Asia Personalized Therapy Biosimulation Platform Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Asia Personalized Therapy Biosimulation Platform Revenue by Region (US$ Million) & (2021-2026) Table 120. Asia Personalized Therapy Biosimulation Platform Revenue by Region (US$ Million) & (2027-2032) Table 121. SAMEA Personalized Therapy Biosimulation Platform Revenue by Type (2021-2026) & (US$ Million) Table 122. SAMEA Personalized Therapy Biosimulation Platform Revenue by Type (2027-2032) & (US$ Million) Table 123. SAMEA Personalized Therapy Biosimulation Platform Revenue by Application (2021-2026) & (US$ Million) Table 124. SAMEA Personalized Therapy Biosimulation Platform Revenue by Application (2027-2032) & (US$ Million) Table 125. SAMEA Personalized Therapy Biosimulation Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. SAMEA Personalized Therapy Biosimulation Platform Revenue by Country (2021-2026) & (US$ Million) Table 127. SAMEA Personalized Therapy Biosimulation Platform Revenue by Country (US$ Million) & (2027-2032) Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Personalized Therapy Biosimulation Platform Image Figure 2. Global Personalized Therapy Biosimulation Platform Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Personalized Therapy Biosimulation Platform Market Size Share 2021 VS 2025 VS 2032 Figure 4. Pharmacokinetic Image Figure 5. Pharmacoeconomics Image Figure 6. Global Personalized Therapy Biosimulation Platform Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Personalized Therapy Biosimulation Platform Market Size Share 2021 VS 2025 VS 2032 Figure 8. Pharmaceutical and Biotech Companies Image Figure 9. Research Institutions Image Figure 10. Hospital Image Figure 11. Others Image Figure 12. Global Personalized Therapy Biosimulation Platform Market Size (US$ Million) & (2021-2032) Figure 13. Global Personalized Therapy Biosimulation Platform Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Personalized Therapy Biosimulation Platform Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Personalized Therapy Biosimulation Platform Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Personalized Therapy Biosimulation Platform Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Personalized Therapy Biosimulation Platform Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Personalized Therapy Biosimulation Platform Revenue Market Share by Type (2021-2032) Figure 20. Global Personalized Therapy Biosimulation Platform Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Personalized Therapy Biosimulation Platform Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Personalized Therapy Biosimulation Platform Revenue Market Share by Application (2021-2032) Figure 23. North America Personalized Therapy Biosimulation Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Personalized Therapy Biosimulation Platform Revenue Share by Type (2021-2032) Figure 25. North America Personalized Therapy Biosimulation Platform Revenue Share by Application (2021-2032) Figure 26. North America Personalized Therapy Biosimulation Platform Revenue Share by Country (2021-2032) Figure 27. United States Personalized Therapy Biosimulation Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Personalized Therapy Biosimulation Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Personalized Therapy Biosimulation Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Personalized Therapy Biosimulation Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Personalized Therapy Biosimulation Platform Revenue Share by Type (2021-2032) Figure 32. Europe Personalized Therapy Biosimulation Platform Revenue Share by Application (2021-2032) Figure 33. Europe Personalized Therapy Biosimulation Platform Revenue Share by Country (2021-2032) Figure 34. Germany Personalized Therapy Biosimulation Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Personalized Therapy Biosimulation Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Personalized Therapy Biosimulation Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Personalized Therapy Biosimulation Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Personalized Therapy Biosimulation Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Personalized Therapy Biosimulation Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Personalized Therapy Biosimulation Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Personalized Therapy Biosimulation Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Personalized Therapy Biosimulation Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Personalized Therapy Biosimulation Platform Revenue Share by Type (2021-2032) Figure 44. China Personalized Therapy Biosimulation Platform Revenue Share by Application (2021-2032) Figure 45. Asia Personalized Therapy Biosimulation Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Personalized Therapy Biosimulation Platform Revenue Share by Type (2021-2032) Figure 47. Asia Personalized Therapy Biosimulation Platform Revenue Share by Application (2021-2032) Figure 48. Asia Personalized Therapy Biosimulation Platform Revenue Share by Region (2021-2032) Figure 49. Japan Personalized Therapy Biosimulation Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Personalized Therapy Biosimulation Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Personalized Therapy Biosimulation Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Personalized Therapy Biosimulation Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Personalized Therapy Biosimulation Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Personalized Therapy Biosimulation Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Personalized Therapy Biosimulation Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Personalized Therapy Biosimulation Platform Revenue Share by Type (2021-2032) Figure 57. SAMEA Personalized Therapy Biosimulation Platform Revenue Share by Application (2021-2032) Figure 58. SAMEA Personalized Therapy Biosimulation Platform Revenue Share by Country (2021-2032) Figure 59. Brazil Personalized Therapy Biosimulation Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Personalized Therapy Biosimulation Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Personalized Therapy Biosimulation Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Personalized Therapy Biosimulation Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Personalized Therapy Biosimulation Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Personalized Therapy Biosimulation Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Personalized Therapy Biosimulation Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Personalized Therapy Biosimulation Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Personalized Therapy Biosimulation Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Personalized Therapy Biosimulation Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Personalized Therapy Biosimulation Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Pharmacokinetic
  • Pharmacoeconomics
Applications
  • Pharmaceutical and Biotech Companies
  • Research Institutions
  • Hospital
  • Others
Companies covered
  • Schrodinger
  • In Silico Biosciences
  • Genedata
  • Physiomics
  • Insilico Biotechology
  • Chemical Computing Group ULC(CCG)
  • Evidera
  • AnyLogic
  • Shanghai Lide
  • Cellworks Group
  • Certara
  • Simulation Plus

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Personalized Therapy Biosimulation Platform Market by Type
  3. 1.2.1 Global Personalized Therapy Biosimulation Platform Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Pharmacokinetic
  5. 1.2.3 Pharmacoeconomics
  6. 1.3 Personalized Therapy Biosimulation Platform Market by Application
  7. 1.3.1 Global Personalized Therapy Biosimulation Platform Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Pharmaceutical and Biotech Companies
  9. 1.3.3 Research Institutions
  10. 1.3.4 Hospital
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Personalized Therapy Biosimulation Platform Market Dynamics
  1. 2.1 Personalized Therapy Biosimulation Platform Industry Trends
  2. 2.2 Personalized Therapy Biosimulation Platform Industry Drivers
  3. 2.3 Personalized Therapy Biosimulation Platform Industry Opportunities and Challenges
  4. 2.4 Personalized Therapy Biosimulation Platform Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Personalized Therapy Biosimulation Platform Market Perspective (2021-2032)
  2. 3.2 Global Personalized Therapy Biosimulation Platform Growth Trends by Region
  3. 3.2.1 Global Personalized Therapy Biosimulation Platform Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Personalized Therapy Biosimulation Platform Market Size by Region (2021-2026)
  5. 3.2.3 Global Personalized Therapy Biosimulation Platform Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Personalized Therapy Biosimulation Platform Revenue by Players
  2. 4.1.1 Global Personalized Therapy Biosimulation Platform Revenue by Players (2021-2026)
  3. 4.1.2 Global Personalized Therapy Biosimulation Platform Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Personalized Therapy Biosimulation Platform Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Personalized Therapy Biosimulation Platform Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Personalized Therapy Biosimulation Platform Key Players Headquarters & Area Served
  7. 4.4 Global Personalized Therapy Biosimulation Platform Players, Product Type & Application
  8. 4.5 Global Personalized Therapy Biosimulation Platform Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Personalized Therapy Biosimulation Platform Market CR5 and HHI
  11. 4.6.3 2025 Personalized Therapy Biosimulation Platform Tier 1, Tier 2, and Tier 3
5 Personalized Therapy Biosimulation Platform Market Size by Type
  1. 5.1 Global Personalized Therapy Biosimulation Platform Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Personalized Therapy Biosimulation Platform Revenue by Type (2021-2032)
  3. 5.3 Global Personalized Therapy Biosimulation Platform Revenue Market Share by Type (2021-2032)
6 Personalized Therapy Biosimulation Platform Market Size by Application
  1. 6.1 Global Personalized Therapy Biosimulation Platform Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Personalized Therapy Biosimulation Platform Revenue by Application (2021-2032)
  3. 6.3 Global Personalized Therapy Biosimulation Platform Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Schrodinger
  2. 7.1.1 Schrodinger Company Information
  3. 7.1.2 Schrodinger Business Overview
  4. 7.1.3 Schrodinger Personalized Therapy Biosimulation Platform Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Schrodinger Personalized Therapy Biosimulation Platform Product Portfolio
  6. 7.1.5 Schrodinger Recent Developments
  7. 7.2 In Silico Biosciences
  8. 7.2.1 In Silico Biosciences Company Information
  9. 7.2.2 In Silico Biosciences Business Overview
  10. 7.2.3 In Silico Biosciences Personalized Therapy Biosimulation Platform Revenue and Gross Margin (2021-2026)
  11. 7.2.4 In Silico Biosciences Personalized Therapy Biosimulation Platform Product Portfolio
  12. 7.2.5 In Silico Biosciences Recent Developments
  13. 7.3 Genedata
  14. 7.3.1 Genedata Company Information
  15. 7.3.2 Genedata Business Overview
  16. 7.3.3 Genedata Personalized Therapy Biosimulation Platform Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Genedata Personalized Therapy Biosimulation Platform Product Portfolio
  18. 7.3.5 Genedata Recent Developments
  19. 7.4 Physiomics
  20. 7.4.1 Physiomics Company Information
  21. 7.4.2 Physiomics Business Overview
  22. 7.4.3 Physiomics Personalized Therapy Biosimulation Platform Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Physiomics Personalized Therapy Biosimulation Platform Product Portfolio
  24. 7.4.5 Physiomics Recent Developments
  25. 7.5 Insilico Biotechology
  26. 7.5.1 Insilico Biotechology Company Information
  27. 7.5.2 Insilico Biotechology Business Overview
  28. 7.5.3 Insilico Biotechology Personalized Therapy Biosimulation Platform Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Insilico Biotechology Personalized Therapy Biosimulation Platform Product Portfolio
  30. 7.5.5 Insilico Biotechology Recent Developments
  31. 7.6 Chemical Computing Group ULC(CCG)
  32. 7.6.1 Chemical Computing Group ULC(CCG) Company Information
  33. 7.6.2 Chemical Computing Group ULC(CCG) Business Overview
  34. 7.6.3 Chemical Computing Group ULC(CCG) Personalized Therapy Biosimulation Platform Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Chemical Computing Group ULC(CCG) Personalized Therapy Biosimulation Platform Product Portfolio
  36. 7.6.5 Chemical Computing Group ULC(CCG) Recent Developments
  37. 7.7 Evidera
  38. 7.7.1 Evidera Company Information
  39. 7.7.2 Evidera Business Overview
  40. 7.7.3 Evidera Personalized Therapy Biosimulation Platform Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Evidera Personalized Therapy Biosimulation Platform Product Portfolio
  42. 7.7.5 Evidera Recent Developments
  43. 7.8 AnyLogic
  44. 7.8.1 AnyLogic Company Information
  45. 7.8.2 AnyLogic Business Overview
  46. 7.8.3 AnyLogic Personalized Therapy Biosimulation Platform Revenue and Gross Margin (2021-2026)
  47. 7.8.4 AnyLogic Personalized Therapy Biosimulation Platform Product Portfolio
  48. 7.8.5 AnyLogic Recent Developments
  49. 7.9 Shanghai Lide
  50. 7.9.1 Shanghai Lide Company Information
  51. 7.9.2 Shanghai Lide Business Overview
  52. 7.9.3 Shanghai Lide Personalized Therapy Biosimulation Platform Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Shanghai Lide Personalized Therapy Biosimulation Platform Product Portfolio
  54. 7.9.5 Shanghai Lide Recent Developments
  55. 7.10 Cellworks Group
  56. 7.10.1 Cellworks Group Company Information
  57. 7.10.2 Cellworks Group Business Overview
  58. 7.10.3 Cellworks Group Personalized Therapy Biosimulation Platform Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Cellworks Group Personalized Therapy Biosimulation Platform Product Portfolio
  60. 7.10.5 Cellworks Group Recent Developments
  61. 7.11 Certara
  62. 7.11.1 Certara Company Information
  63. 7.11.2 Certara Business Overview
  64. 7.11.3 Certara Personalized Therapy Biosimulation Platform Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Certara Personalized Therapy Biosimulation Platform Product Portfolio
  66. 7.11.5 Certara Recent Developments
  67. 7.12 Simulation Plus
  68. 7.12.1 Simulation Plus Company Information
  69. 7.12.2 Simulation Plus Business Overview
  70. 7.12.3 Simulation Plus Personalized Therapy Biosimulation Platform Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Simulation Plus Personalized Therapy Biosimulation Platform Product Portfolio
  72. 7.12.5 Simulation Plus Recent Developments
8 North America
  1. 8.1 North America Personalized Therapy Biosimulation Platform Revenue (2021-2032)
  2. 8.2 North America Personalized Therapy Biosimulation Platform Revenue by Type (2021-2032)
  3. 8.2.1 North America Personalized Therapy Biosimulation Platform Revenue by Type (2021-2026)
  4. 8.2.2 North America Personalized Therapy Biosimulation Platform Revenue by Type (2027-2032)
  5. 8.3 North America Personalized Therapy Biosimulation Platform Revenue Share by Type (2021-2032)
  6. 8.4 North America Personalized Therapy Biosimulation Platform Revenue by Application (2021-2032)
  7. 8.4.1 North America Personalized Therapy Biosimulation Platform Revenue by Application (2021-2026)
  8. 8.4.2 North America Personalized Therapy Biosimulation Platform Revenue by Application (2027-2032)
  9. 8.5 North America Personalized Therapy Biosimulation Platform Revenue Share by Application (2021-2032)
  10. 8.6 North America Personalized Therapy Biosimulation Platform Revenue by Country
  11. 8.6.1 North America Personalized Therapy Biosimulation Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Personalized Therapy Biosimulation Platform Revenue by Country (2021-2026)
  13. 8.6.3 North America Personalized Therapy Biosimulation Platform Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Personalized Therapy Biosimulation Platform Revenue (2021-2032)
  2. 9.2 Europe Personalized Therapy Biosimulation Platform Revenue by Type (2021-2032)
  3. 9.2.1 Europe Personalized Therapy Biosimulation Platform Revenue by Type (2021-2026)
  4. 9.2.2 Europe Personalized Therapy Biosimulation Platform Revenue by Type (2027-2032)
  5. 9.3 Europe Personalized Therapy Biosimulation Platform Revenue Share by Type (2021-2032)
  6. 9.4 Europe Personalized Therapy Biosimulation Platform Revenue by Application (2021-2032)
  7. 9.4.1 Europe Personalized Therapy Biosimulation Platform Revenue by Application (2021-2026)
  8. 9.4.2 Europe Personalized Therapy Biosimulation Platform Revenue by Application (2027-2032)
  9. 9.5 Europe Personalized Therapy Biosimulation Platform Revenue Share by Application (2021-2032)
  10. 9.6 Europe Personalized Therapy Biosimulation Platform Revenue by Country
  11. 9.6.1 Europe Personalized Therapy Biosimulation Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Personalized Therapy Biosimulation Platform Revenue by Country (2021-2026)
  13. 9.6.3 Europe Personalized Therapy Biosimulation Platform Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Personalized Therapy Biosimulation Platform Revenue (2021-2032)
  2. 10.2 China Personalized Therapy Biosimulation Platform Revenue by Type (2021-2032)
  3. 10.2.1 China Personalized Therapy Biosimulation Platform Revenue by Type (2021-2026)
  4. 10.2.2 China Personalized Therapy Biosimulation Platform Revenue by Type (2027-2032)
  5. 10.3 China Personalized Therapy Biosimulation Platform Revenue Share by Type (2021-2032)
  6. 10.4 China Personalized Therapy Biosimulation Platform Revenue by Application (2021-2032)
  7. 10.4.1 China Personalized Therapy Biosimulation Platform Revenue by Application (2021-2026)
  8. 10.4.2 China Personalized Therapy Biosimulation Platform Revenue by Application (2027-2032)
  9. 10.5 China Personalized Therapy Biosimulation Platform Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Personalized Therapy Biosimulation Platform Revenue (2021-2032)
  2. 11.2 Asia Personalized Therapy Biosimulation Platform Revenue by Type (2021-2032)
  3. 11.2.1 Asia Personalized Therapy Biosimulation Platform Revenue by Type (2021-2026)
  4. 11.2.2 Asia Personalized Therapy Biosimulation Platform Revenue by Type (2027-2032)
  5. 11.3 Asia Personalized Therapy Biosimulation Platform Revenue Share by Type (2021-2032)
  6. 11.4 Asia Personalized Therapy Biosimulation Platform Revenue by Application (2021-2032)
  7. 11.4.1 Asia Personalized Therapy Biosimulation Platform Revenue by Application (2021-2026)
  8. 11.4.2 Asia Personalized Therapy Biosimulation Platform Revenue by Application (2027-2032)
  9. 11.5 Asia Personalized Therapy Biosimulation Platform Revenue Share by Application (2021-2032)
  10. 11.6 Asia Personalized Therapy Biosimulation Platform Revenue by Country
  11. 11.6.1 Asia Personalized Therapy Biosimulation Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Personalized Therapy Biosimulation Platform Revenue by Country (2021-2026)
  13. 11.6.3 Asia Personalized Therapy Biosimulation Platform Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Personalized Therapy Biosimulation Platform Revenue (2021-2032)
  2. 12.2 SAMEA Personalized Therapy Biosimulation Platform Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Personalized Therapy Biosimulation Platform Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Personalized Therapy Biosimulation Platform Revenue by Type (2027-2032)
  5. 12.3 SAMEA Personalized Therapy Biosimulation Platform Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Personalized Therapy Biosimulation Platform Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Personalized Therapy Biosimulation Platform Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Personalized Therapy Biosimulation Platform Revenue by Application (2027-2032)
  9. 12.5 SAMEA Personalized Therapy Biosimulation Platform Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Personalized Therapy Biosimulation Platform Revenue by Country
  11. 12.6.1 SAMEA Personalized Therapy Biosimulation Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Personalized Therapy Biosimulation Platform Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Personalized Therapy Biosimulation Platform Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst